+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell and Gene Therapy Third-Party Logistics Market Size, Share & Trends Analysis Report by Type (Clinical), Product (Cell Therapies, Gene Therapies), Temperature Range (Ambient Storage), Therapeutic Area, End-use, Region, with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 150 Pages
  • April 2025
  • Region: Global
  • Grand View Research
  • ID: 6085876
Description Jump to:
The Cell and Gene Therapy Third-Party Logistics Market was valued at USD 10.71 Billion in 2024, and is projected to reach USD 20.04 Billion by 2030, rising at a CAGR of 11.05%. The growth of the market is mainly due to rising demand for cell and gene therapies, which require precise handling, strict temperature controls, and seamless coordination between manufacturers, hospitals, and treatment centers. CGTs are patient-specific, which signifies that a single patient’s cells must be collected, transported, modified, and reinfused within tight timelines. Any failure in logistics can result in the loss of an expensive, potentially life-saving therapy. The personalized nature of CGTs has increased the need for advanced cold chain logistics, with cryogenic storage and ultra-low temperature transportation becoming standard requirements.

In addition, the growing pipeline of CGT clinical trials and commercial approvals encourages logistics providers to scale their capabilities, ensuring that the increasing volume of therapies reaches patients without compromising quality. This shift is compelling biopharmaceutical companies to seek specialized 3PL partners that can handle the complexities of CGT supply chains, ensuring compliance with strict regulatory requirements while optimizing distribution efficiency. Moreover, the growing regulatory support is also one of the factors contributing to market growth. The U.S. FDA, EMA, and other global regulatory bodies impose stringent guidelines on the transportation and storage of CGTs to maintain their potency and safety. Regulatory compliance requires logistics providers to implement Good Distribution Practices (GDP) and Good Manufacturing Practices (GMP) standards, which govern every aspect of supply chain management, from packaging to real-time tracking. Failure to comply can result in rejected shipments, financial losses, and treatment delays for patients.

Furthermore, growing initiatives by the market players, such as partnerships and collaborations, service expansion, product launches, and increasing pipeline products, contribute to market growth. For instance, in March 2025, DHL acquired CryoPDP, a specialist in temperature-controlled logistics for life sciences. The acquisition aims to strengthen the infrastructure for handling advanced therapies. CryoPDP’s expertise in ultra-cold storage and real-time monitoring solutions aligns with DHL’s strategy, providing end-to-end solutions for biopharma companies.

Cell and Gene Therapy Third-Party Logistics Market Report Highlights

  • Based on type, the clinical segment dominated the market due to the increasing number of research and development activities by the market players coupled with the growing number of cell and gene therapies product pipelines.
  • Based on the product, cell therapies dominated the market in 2024 due to increasing regulatory approvals and expanding commercialization efforts. The success of CAR-T cell therapies for cancer treatment played a crucial role in this growth, with companies like Novartis, Gilead Sciences, and Bristol Myers Squibb driving widespread adoption.
  • Based on temperature range, ambient storage held the largest market share in 2024due to the increasing demand for gene therapies, biologics, and regenerative medicine products that do not require ultra-low or cryogenic temperatures.
  • Based on the therapeutic area, the oncology segment dominated the market in 2024due to the rapid adoption of advanced therapies for treating various cancers, particularly hematologic and solid tumors.
  • Based on end use, biopharmaceutical companies held the largest market share in 2024due to their high reliance on temperature-controlled storage and transportation for biologics and specialty drugs.

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Regional Scope
1.1.2. Estimates and Forecast Timeline
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Purchased Database
1.3.3. Internal Database
1.3.4. Secondary Sources
1.3.5. Primary Research
1.4. Information or Data Analysis
1.4.1. Information Analysis
1.4.2. Market Formulation & Data Visualization
1.4.3. Data Validation & Publishing
1.5. Model Details
1.5.1. Commodity Flow Analysis (Model 1)
1.5.2. Top Down Market Estimation (Model 2)
1.5.3. Value-Chain-Based Sizing & Forecasting (Model 3)
1.5.4. Multivariate Analysis (Model 4)
1.6. List of Secondary Sources
1.7. List of Abbreviations
1.8. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Technology Landscape
3.5. Pricing Model Analysis
3.6. Industry Analysis Tools
3.6.1. Porter’s Five Forces Analysis
3.6.2. PESTEL Analysis
3.6.3. COVID-19 Impact Analysis
Chapter 4. Cell & Gene Therapy Third-Party Logistics Market: Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Cell & Gene Therapy Third-Party Logistics Market; Type Movement Analysis
4.3. Cell & Gene Therapy Third-Party Logistics Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
4.4. Clinical
4.4.1. Clinical market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Commercial
4.5.1. Commercial market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Cell & Gene Therapy Third-Party Logistics Market: Product Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Cell & Gene Therapy Third-Party Logistics Market; Product Movement Analysis
5.3. Cell & Gene Therapy Third-Party Logistics Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
5.4. Cell Therapies
5.4.1. Cell therapies market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Gene Therapies
5.5.1. Gene therapies market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Cell & Gene Therapy Third-Party Logistics Market: Temperature Range Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Cell & Gene Therapy Third-Party Logistics Market; Temperature Range Movement Analysis
6.3. Cell & Gene Therapy Third-Party Logistics Size & Trend Analysis, by Temperature Range, 2018 to 2030 (USD Million)
6.4. Ambient Storage
6.4.1. Ambient storage market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Refrigerated Storage
6.5.1. Refrigerated storage market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Ultra-Low Temperature Storage
6.6.1. Ultra-Low temperature storage market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Cryogenic Storage
6.7.1. Cryogenic storage market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Cell & Gene Therapy Third-Party Logistics Market: Therapeutic Area Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Cell & Gene Therapy Third-Party Logistics Market; Therapeutic Area Movement Analysis
7.3. Cell & Gene Therapy Third-Party Logistics Size & Trend Analysis, by Therapeutic Area, 2018 to 2030 (USD Million)
7.4. Oncology
7.4.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Neurology
7.5.1. Neurology market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Cardiovascular Diseases
7.6.1. Cardiovascular diseases market estimates and forecasts, 2018 to 2030 (USD Million)
7.7. Ophthalmology
7.7.1. Ophthalmology market estimates and forecasts, 2018 to 2030 (USD Million)
7.8. Infectious Diseases
7.8.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
7.9. Others
7.9.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Cell & Gene Therapy Third-Party Logistics Market: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Cell & Gene Therapy Third-Party Logistics Market; End Use Movement Analysis
8.3. Cell & Gene Therapy Third-Party Logistics Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
8.4. Biopharmaceutical Companies
8.4.1. Biopharmaceutical Companies market estimates and forecasts, 2018 to 2030 (USD Million)
8.5. CDMOs/CMOs
8.5.1. CDMOs/CMOs market estimates and forecasts, 2018 to 2030 (USD Million)
8.6. Others
8.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 9. Regional Business Analysis
9.1. Regional Dashboard
9.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
9.3. North America
9.3.1. North America cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.3.2. U.S.
9.3.2.1. Key country dynamics
9.3.2.2. Competitive scenario
9.3.2.3. Regulatory framework
9.3.2.4. U.S. cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.3.3. Canada
9.3.3.1. Key country dynamics
9.3.3.2. Competitive scenario
9.3.3.3. Regulatory framework
9.3.3.4. Canada cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.3.4. Mexico
9.3.4.1. Key country dynamics
9.3.4.2. Competitive scenario
9.3.4.3. Regulatory framework
9.3.4.4. Mexico cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.4. Europe
9.4.1. Europe cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.4.2. Germany
9.4.2.1. Key country dynamics
9.4.2.2. Competitive scenario
9.4.2.3. Regulatory framework
9.4.2.4. Germany cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.4.3. UK
9.4.3.1. Key country dynamics
9.4.3.2. Competitive scenario
9.4.3.3. Regulatory framework
9.4.3.4. UK cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.4.4. France
9.4.4.1. Key country dynamics
9.4.4.2. Competitive scenario
9.4.4.3. Regulatory framework
9.4.4.4. France cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.4.5. Italy
9.4.5.1. Key country dynamics
9.4.5.2. Competitive scenario
9.4.5.3. Regulatory framework
9.4.5.4. Italy cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.4.6. Spain
9.4.6.1. Key country dynamics
9.4.6.2. Competitive scenario
9.4.6.3. Regulatory framework
9.4.6.4. Spain cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.4.7. Denmark
9.4.7.1. Key country dynamics
9.4.7.2. Competitive scenario
9.4.7.3. Regulatory framework
9.4.7.4. Denmark cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.4.8. Sweden
9.4.8.1. Key country dynamics
9.4.8.2. Competitive scenario
9.4.8.3. Regulatory framework
9.4.8.4. Sweden cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.4.9. Norway
9.4.9.1. Key country dynamics
9.4.9.2. Competitive scenario
9.4.9.3. Regulatory framework
9.4.9.4. Norway cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.5. Asia Pacific
9.5.1. Asia Pacific cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.5.2. Japan
9.5.2.1. Key country dynamics
9.5.2.2. Competitive scenario
9.5.2.3. Regulatory framework
9.5.2.4. Japan cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.5.3. China
9.5.3.1. Key country dynamics
9.5.3.2. Competitive scenario
9.5.3.3. Regulatory framework
9.5.3.4. China cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.5.4. India
9.5.4.1. Key country dynamics
9.5.4.2. Competitive scenario
9.5.4.3. Regulatory framework
9.5.4.4. India cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.5.5. South Korea
9.5.5.1. Key country dynamics
9.5.5.2. Competitive scenario
9.5.5.3. Regulatory framework
9.5.5.4. South Korea cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.5.6. Australia
9.5.6.1. Key country dynamics
9.5.6.2. Competitive scenario
9.5.6.3. Regulatory framework
9.5.6.4. Australia cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.5.7. Thailand
9.5.7.1. Key country dynamics
9.5.7.2. Competitive scenario
9.5.7.3. Regulatory framework
9.5.7.4. Thailand cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.6. Latin America
9.6.1. Latin America cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.6.2. Brazil
9.6.2.1. Key country dynamics
9.6.2.2. Competitive scenario
9.6.2.3. Regulatory framework
9.6.2.4. Brazil cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.6.3. Argentina
9.6.3.1. Key country dynamics
9.6.3.2. Competitive scenario
9.6.3.3. Regulatory framework
9.6.3.4. Argentina cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.7. MEA
9.7.1. MEA cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.7.2. South Africa
9.7.2.1. Key country dynamics
9.7.2.2. Competitive scenario
9.7.2.3. Regulatory framework
9.7.2.4. South Africa cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.7.3. Saudi Arabia
9.7.3.1. Key country dynamics
9.7.3.2. Competitive scenario
9.7.3.3. Regulatory framework
9.7.3.4. Saudi Arabia cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.7.4. UAE
9.7.4.1. Key country dynamics
9.7.4.2. Competitive scenario
9.7.4.3. Regulatory framework
9.7.4.4. UAE cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
9.7.5. Kuwait
9.7.5.1. Key country dynamics
9.7.5.2. Competitive scenario
9.7.5.3. Regulatory framework
9.7.5.4. Kuwait cell & gene therapy third-party logistics market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 10. Competitive Landscape
10.1. Company Categorization
10.2. Company Market Share/Assessment Analysis, 2024
10.3. Company Profiles
10.3.1. Cencora Corporation
10.3.1.1. Company overview
10.3.1.2. Financial performance
10.3.1.3. Service benchmarking
10.3.1.4. Strategic initiatives
10.3.2. Cardinal Health
10.3.2.1. Company overview
10.3.2.2. Financial performance
10.3.2.3. Service benchmarking
10.3.2.4. Strategic initiatives
10.3.3. McKesson Corporation
10.3.3.1. Company overview
10.3.3.2. Financial performance
10.3.3.3. Service benchmarking
10.3.3.4. Strategic initiatives
10.3.4. EVERSANA
10.3.4.1. Company overview
10.3.4.2. Financial performance
10.3.4.3. Service benchmarking
10.3.4.4. Strategic initiatives
10.3.5. Knipper Health
10.3.5.1. Company overview
10.3.5.2. Financial performance
10.3.5.3. Service benchmarking
10.3.5.4. Strategic initiatives
10.3.6. Arvato SE
10.3.6.1. Company overview
10.3.6.2. Financial performance
10.3.6.3. Service benchmarking
10.3.6.4. Strategic initiatives
10.3.7. DHL
10.3.7.1. Company overview
10.3.7.2. Financial performance
10.3.7.3. Service benchmarking
10.3.7.4. Strategic initiatives
10.3.8. FedEx
10.3.8.1. Company overview
10.3.8.2. Financial performance
10.3.8.3. Service benchmarking
10.3.8.4. Strategic initiatives
10.3.9. Kuehne+Nagel
10.3.9.1. Company overview
10.3.9.2. Financial performance
10.3.9.3. Service benchmarking
10.3.9.4. Strategic initiatives
10.3.10. United Parcel Service of America, Inc.
10.3.10.1. Company overview
10.3.10.2. Financial performance
10.3.10.3. Service benchmarking
10.3.10.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 4 Global Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 5 Global Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 6 Global Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 7 Global Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 8 Global Cell & Gene Therapy Third-Party Logistics Market, by Region, 2018-2030 (USD Million)
Table 9 North America Cell & Gene Therapy Third-Party Logistics Market, by Country, 2018-2030 (USD Million)
Table 10 North America Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 11 North America Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 12 North America Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 13 North America Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 14 North America Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 15 U.S. Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 16 U.S. Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 17 U.S. Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 18 U.S. Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 19 U.S. Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 20 Canada Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 21 Canada Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 22 Canada Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 23 Canada Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 24 Canada Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 25 Mexico Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 26 Mexico Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 27 Mexico Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 28 Mexico Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 29 Mexico Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 30 Europe Cell & Gene Therapy Third-Party Logistics Market, by Country, 2018-2030 (USD Million)
Table 31 Europe Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 32 Europe Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 33 Europe Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 34 Europe Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 35 Europe Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 36 UK Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 37 UK Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 38 UK Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 39 UK Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 40 UK Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 41 Germany Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 42 Germany Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 43 Germany Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 44 Germany Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 45 Germany Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 46 France Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 47 France Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 48 France Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 49 France Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 50 France Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 51 Italy Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 52 Italy Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 53 Italy Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 54 Italy Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 55 Italy Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 56 Spain Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 57 Spain Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 58 Spain Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 59 Spain Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 60 Spain Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 61 Denmark Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 62 Denmark Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 63 Denmark Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 64 Denmark Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 65 Denmark Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 66 Sweden Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 67 Sweden Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 68 Sweden Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 69 Sweden Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 70 Sweden Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 71 Norway Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 72 Norway Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 73 Norway Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 74 Norway Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 75 Norway Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 76 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by Country, 2018-2030 (USD Million)
Table 77 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 78 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 79 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 80 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 81 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 82 Japan Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 83 Japan Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 84 Japan Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 85 Japan Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 86 Japan Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 87 China Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 88 China Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 89 China Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 90 China Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 91 China Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 92 India Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 93 India Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 94 India Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 95 India Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 96 India Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 97 Australia Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 98 Australia Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 99 Australia Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 100 Australia Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 101 Australia Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 102 South Korea Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 103 South Korea Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 104 South Korea Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 105 South Korea Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 106 South Korea Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 107 Thailand Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 108 Thailand Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 109 Thailand Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 110 Thailand Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 111 Thailand Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 112 Latin America Cell & Gene Therapy Third-Party Logistics Market, by Country, 2018-2030 (USD Million)
Table 113 Latin America Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 114 Latin America Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 115 Latin America Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 116 Latin America Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 117 Latin America Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 118 Brazil Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 119 Brazil Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 120 Brazil Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 121 Brazil Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 122 Brazil Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 123 Argentina Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 124 Argentina Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 125 Argentina Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 126 Argentina Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 127 Argentina Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 128 MEA Cell & Gene Therapy Third-Party Logistics Market, by Country, 2018-2030 (USD Million)
Table 129 MEA Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 130 MEA Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 131 MEA Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 132 MEA Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 133 MEA Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 134 South Africa Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 135 South Africa Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 136 South Africa Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 137 South Africa Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 138 South Africa Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 139 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 140 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 141 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 142 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 143 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 144 UAE Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 145 UAE Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 146 UAE Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 147 UAE Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 148 UAE Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
Table 149 Kuwait Cell & Gene Therapy Third-Party Logistics Market, by Type, 2018-2030 (USD Million)
Table 150 Kuwait Cell & Gene Therapy Third-Party Logistics Market, by Product, 2018-2030 (USD Million)
Table 151 Kuwait Cell & Gene Therapy Third-Party Logistics Market, by Temperature Range, 2018-2030 (USD Million)
Table 152 Kuwait Cell & Gene Therapy Third-Party Logistics Market, by Therapeutic Area, 2018-2030 (USD Million)
Table 153 Kuwait Cell & Gene Therapy Third-Party Logistics Market, by End Use, 2018-2030 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Information Procurement
Figure 3 Market Research Approaches
Figure 4 Value Chain-Based Sizing & Forecasting
Figure 5 Market Formulation & Validation
Figure 6 Cell & Gene Therapy Third-Party Logistics Market Segmentation
Figure 7 Market Snapshot, 2024
Figure 8 Market Trends & Outlook
Figure 9 Market Driver Relevance Analysis (Current & Future Impact)
Figure 10 Market Restraint Relevance Analysis (Current & Future Impact)
Figure 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
Figure 12 Porter’s Five Forces Analysis
Figure 13 Global Cell & Gene Therapy Third-Party Logistics Market: Type Key Takeaways
Figure 14 Global Cell & Gene Therapy Third-Party Logistics Market: Type Movement Analysis
Figure 15 Global Cell & Gene Therapy Third-Party Logistics Market, for Clinical, 2018-2030 (USD Million)
Figure 16 Global Cell & Gene Therapy Third-Party Logistics Market, for Commercial, 2018-2030 (USD Million)
Figure 17 Global Cell & Gene Therapy Third-Party Logistics Market: Product Key Takeaways
Figure 18 Global Cell & Gene Therapy Third-Party Logistics Market: Product Movement Analysis
Figure 19 Global Cell & Gene Therapy Third-Party Logistics Market, for Cell Therapies, 2018-2030 (USD Million)
Figure 20 Global Cell & Gene Therapy Third-Party Logistics Market, for Gene Therapies, 2018-2030 (USD Million)
Figure 21 Global Cell & Gene Therapy Third-Party Logistics Market: Temperature Range Key Takeaways
Figure 22 Global Cell & Gene Therapy Third-Party Logistics Market, Temperature Range Movement Analysis
Figure 23 Global Cell & Gene Therapy Third-Party Logistics Market, for Ambient Storage, 2018-2030 (USD Million)
Figure 24 Global Cell & Gene Therapy Third-Party Logistics Market, for Refrigerated Storage, 2018-2030 (USD Million)
Figure 25 Global Cell & Gene Therapy Third-Party Logistics Market, for Ultra-Low Temperature Storage, 2018-2030 (USD Million)
Figure 26 Global Cell & Gene Therapy Third-Party Logistics Market, for Cryogenic Storage, 2018-2030 (USD Million)
Figure 27 Global Cell & Gene Therapy Third-Party Logistics Market: Therapeutic Area Key Takeaways
Figure 28 Global Cell & Gene Therapy Third-Party Logistics Market, Therapeutic Area Movement Analysis
Figure 29 Global Cell & Gene Therapy Third-Party Logistics Market, Oncology, 2018-2030 (USD Million)
Figure 30 Global Cell & Gene Therapy Third-Party Logistics Market, for Neurology, 2018-2030 (USD Million)
Figure 31 Global Cell & Gene Therapy Third-Party Logistics Market, for cardiovascular diseases, 2018-2030 (USD Million)
Figure 32 Global Cell & Gene Therapy Third-Party Logistics Market, for Ophthalmology, 2018-2030 (USD Million)
Figure 33 Global Cell & Gene Therapy Third-Party Logistics Market, for Infectious Diseases, 2018-2030 (USD Million)
Figure 34 Global Cell & Gene Therapy Third-Party Logistics Market, for Others, 2018-2030 (USD Million)
Figure 35 Global Cell & Gene Therapy Third-Party Logistics Market: End Use Key Takeaways
Figure 36 Global Cell & Gene Therapy Third-Party Logistics Market, End Use Movement Analysis
Figure 37 Global Cell & Gene Therapy Third-Party Logistics Market, for Biopharmaceutical Companies, 2018-2030 (USD Million)
Figure 38 Global Cell & Gene Therapy Third-Party Logistics Market, for CDMOs/CMOs, 2018-2030 (USD Million)
Figure 39 Global Cell & Gene Therapy Third-Party Logistics Market, for Others, 2018-2030 (USD Million)
Figure 40 Regional Marketplace: Key Takeaways
Figure 41 Regional Outlook, 2024 & 2030
Figure 42 North America Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 43 U.S. Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 44 Canada Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 45 Mexico Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 46 Europe Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 47 Germany Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 48 UK Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 49 France Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 50 Italy Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 51 Spain Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 52 Denmark Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 53 Sweden Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 54 Norway Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 55 Asia Pacific Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 56 Japan Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 57 China Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 58 India Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 59 Australia Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 60 South Korea Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 61 Thailand Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 62 Latin America Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 63 Brazil Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 64 Argentina Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 65 Middle East and Africa Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 66 South Africa Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 67 Saudi Arabia Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 68 UAE Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)
Figure 69 Kuwait Cell & Gene Therapy Third-Party Logistics Market, 2018-2030 (USD Million)

Companies Mentioned

The companies profiled in this Cell and Gene Therapy Third-Party Logistics market report include:
  • Cencora Corporation
  • Cardinal Health
  • McKesson Corporation
  • EVERSANA
  • Knipper Health
  • Arvato SE
  • DHL
  • FedEx
  • Kuehne + Nagel
  • United Parcel Service of America, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages150
PublishedApril 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 10.71 Billion
Forecasted Market Value ( USD ) by 2030 $ 20.04 Billion
Compound Annual Growth Rate11.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Biopharmaceutical Third Party Logistics Market - Global Forecast to 2030 - Product Image

Biopharmaceutical Third Party Logistics Market - Global Forecast to 2030

  • Report
  • 195 Pages
  • Global
From
U.S. Pharmaceutical Third-party Logistics Services Market Size, Share & Trends Analysis Report By Product Type (Branded, Cell Therapy, Biosimilar), By Temperature (Ambient, Refrigerated), By Therapeutic Area, By Manufacturer Size, By Service, And Segment Forecasts, 2025 - 2030 - Product Image

U.S. Pharmaceutical Third-party Logistics Services Market Size, Share & Trends Analysis Report By Product Type (Branded, Cell Therapy, Biosimilar), By Temperature (Ambient, Refrigerated), By Therapeutic Area, By Manufacturer Size, By Service, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • United States
From
Cell and Gene Therapy Third-Party Logistics Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Cell and Gene Therapy Third-Party Logistics Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • Global
From
Pharmaceutical Third-Party Logistics Market Size, Share & Trends Analysis Report By Product (Branded, Generic, Biosimilar), By Temperature (Ambient, Refrigerated), By Therapeutic Area, By Manufacturer Size, By Service, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Pharmaceutical Third-Party Logistics Market Size, Share & Trends Analysis Report By Product (Branded, Generic, Biosimilar), By Temperature (Ambient, Refrigerated), By Therapeutic Area, By Manufacturer Size, By Service, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Healthcare Cold Chain Third Party Logistics Market Size, Share & Trends Analysis Report by Service (Warehousing & Storage, Packaging Solutions), Product (Biopharmaceuticals), Temperature Range, End Use, and Region with Growth Forecasts, 2025-2030 - Product Image

Healthcare Cold Chain Third Party Logistics Market Size, Share & Trends Analysis Report by Service (Warehousing & Storage, Packaging Solutions), Product (Biopharmaceuticals), Temperature Range, End Use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.